Skip to main content

Articles

Page 8 of 16

  1. Authors: Andrzej Plawski, Paweł Boruń, Tomasz Banasiewicz, Jacek Paszkowski, Agnieszka Stembalska, Maria Sąsiadek, Monika Siołek, Beata Kozak - Klonowska, Izabela Brozek, Janusz Limon, Dorota Nowakowska, Grzegorz Kurzawski, Tomasz Byrski, Tomasz Gach, Diana Hodorowicz-Zaniewska, Anna Bartkowiak…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A24

    This article is part of a Supplement: Volume 10 Supplement 4

  2. Authors: T T Huzarski, B Górecka-Szyld, J J Huzarska, G Psut, G Wilk, R Sibilski, C Cybulski, B Kozak-Klonowska, M Siołek, E Kilar, D Czudowska, H Janiszewska, D Godlewski, A Mackiewicz, J Jarkiewicz-Tretyn, I Szabo-Moskal…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A18

    This article is part of a Supplement: Volume 10 Supplement 4

  3. Authors: Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko-Grabarek, Oleg Oszurek, Anna Jakubowska, Antoni Morawski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A5

    This article is part of a Supplement: Volume 10 Supplement 4

  4. Authors: Katarzyna Jaworska - Bieniek, Anna Jakubowska, Katarzyna Durda, Tomasz Huzarski, Pablo Serrano-Fernandez, Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Byrski, Jacek Gronwald, Satish Gupta, Katarzyna Kaczmarek and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A4

    This article is part of a Supplement: Volume 10 Supplement 4

  5. Authors: Katrzyna Jaworska-Bieniek, Satish Gupta, Katarzyna Durda, Magdalena Muszynska, Grzegorz Sukiennicki, Elżbieta Jaworowska, Tomasz Grodzki, Mieczysław Sulikowski, Piotr Woloszczyk, Janusz Wójcik, Jakub Lubiński, Cezary Cybulski, Tadeusz Dębniak, Marcin Lener, Steven A Narod, Ping Sun…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A2

    This article is part of a Supplement: Volume 10 Supplement 4

  6. During the past decade many new molecular methods for DNA and RNA analysis have emerged. The most popular thus far have been SSCP, HET, CMC, DGGE, RFLP or ASA, which have now been replaced by methods that are ...

    Authors: Grzegorz Kurzawski, Dagmara Dymerska, Pablo Serrano-Fernández, Joanna Trubicka, Bartłomiej Masojć, Anna Jakubowska and Rodney J Scott
    Citation: Hereditary Cancer in Clinical Practice 2012 10:17
  7. Chemokine and chemokine receptors play an essential role in tumorigenesis. Although chemokine-associated single nucleotide polymorphisms (SNPs) are associated with various cancers, their impact on prostate can...

    Authors: LaCreis R Kidd, Dominique Z Jones, Erica N Rogers, Nayla C Kidd, Sydney Beache, James E Rudd, Camille Ragin, Maria Jackson, Norma McFarlane-Anderson, Marshall Tulloch-Reid, Seian Morrison, Guy N Brock, Shirish S Barve and Kevin S Kimbro
    Citation: Hereditary Cancer in Clinical Practice 2012 10:16
  8. Café au lait spots (CALS) are common dermatologic findings that can at the same time arise in a variety of pathologic conditions such as Neurofibromatosis type 1 (NF1), together with numerous hereditary syndro...

    Authors: Giovanni Ponti, Aldo Tomasi, Lorenza Pastorino, Cristel Ruini, Carmelo Guarneri, Victor Desmond Mandel, Stefania Seidenari and Giovanni Pellacani
    Citation: Hereditary Cancer in Clinical Practice 2012 10:15
  9. The mutations of the RET proto-oncogene contributes to the development of MTC by increasing the activity of the receptor encoded by this gene. Variant T of polymorphism rs2435357 located in the enhancer of the...

    Authors: Pawel Borun, Sowinski Jerzy, Katarzyna Ziemnicka, Lukasz Kubaszewski, Daniel Lipinski and Andrzej Plawski
    Citation: Hereditary Cancer in Clinical Practice 2012 10:14
  10. Mutations in FLCN cause Birt-Hogg-Dubé syndrome, an autosomal dominant disorder notable for development of cutaneous fibrofolliculomas or trichodiscomas, a variety of renal tumors, and spontaneous pneumothorax du...

    Authors: Noralane M Lindor, Jan Kasperbauer, Jean E Lewis and Mark Pittelkow
    Citation: Hereditary Cancer in Clinical Practice 2012 10:13
  11. Paragangliomas are rare tumours with a prevalence of 1/10000 to 1/30000. Tumors arising from the paraganglia are characteristically of low malignant potential. Vertebral metastases are exceedingly rare, and on...

    Authors: Manuel Eduardo Ribeiro da Silva, Manuel João Queiroz de Fariados Santos Carvalho, António Pedro Cacho Rodrigues, Nuno Silva Morais Neves, António Moura Gonçalves, Rui Alexandre Peixoto Pinto and Davide Carvalho
    Citation: Hereditary Cancer in Clinical Practice 2012 10:12
  12. Cyclin-dependent kinase 4 (CDK4) together with its regulatory subunit cyclin D1, governs cell cycle progression through G1 phase. Cyclin-dependent kinase inhibitors, including p16INK4A in turn regulate CDK4. In p...

    Authors: Maimoona Sabir, Ruqia Mehmood Baig, Ishrat Mahjabeen and Mahmood Akhtar Kayani
    Citation: Hereditary Cancer in Clinical Practice 2012 10:11
  13. The molecular etiology of thyroid carcinoma (TC) and other thyroid diseases which may present malignant precursor lesions is not fully explored yet. The purpose of this study was to estimate frequency, type an...

    Authors: Hans-Juergen Schulten, Sherine Salama, Zuhoor Al-Mansouri, Reem Alotibi, Khalid Al-Ghamdi, Osman Abdel Al-Hamour, Hassan Sayadi, Hosam Al-Aradati, Adel Al-Johari, Etimad Huwait, Mamdooh Gari, Mohammed Hussain Al-Qahtani and Jaudah Al-Maghrabi
    Citation: Hereditary Cancer in Clinical Practice 2012 10:10
  14. With the discovery that the hereditary cancer susceptibility disease Lynch syndrome (LS) is caused by deleterious germline mutations in the DNA mismatch repair (MMR) genes nearly 20 years ago, genetic testing ...

    Authors: Christopher D Heinen and LJ Rasmussen
    Citation: Hereditary Cancer in Clinical Practice 2012 10:9
  15. Pancreatic cancer (PC) is considered the most lethal cancer and approximately 10% of PC is hereditary. The purpose of the study was to assess attitudes of at-risk family members with two or more relatives affe...

    Authors: Carmen Radecki Breitkopf, Pamela S Sinicrope, Kari G Rabe, Tabetha A Brockman, Christi A Patten, Robert R McWilliams, Shawna Ehlers and Gloria M Petersen
    Citation: Hereditary Cancer in Clinical Practice 2012 10:8
  16. Breast cancer is the most prevalent malignancy in women in Western countries, currently accounting for one third of all female cancers. Familial aggregation is thought to account for 5–10 % of all BC cases, an...

    Authors: Nadine Jalkh, Jinane Nassar-Slaba, Eliane Chouery, Nabiha Salem, Nancy Uhrchammer, Lisa Golmard, Domique Stoppa-Lyonnet, Yves-Jean Bignon and André Mégarbané
    Citation: Hereditary Cancer in Clinical Practice 2012 10:7
  17. A growing number of individuals are diagnosed with hereditary cancer. Though increased levels of anxiety and depression have been demonstrated around the time of genetic counselling, most individuals handle li...

    Authors: Katarina Bartuma, Mef Nilbert and Christina Carlsson
    Citation: Hereditary Cancer in Clinical Practice 2012 10:6
  18. Authors: Urszula Teodorczyk, Cezary Cybulski, Anna Jakubowska, Teresa Starzyńska, Małgorzata Ławniczak, Paweł Domagała, Katarzyna Ferenc, Krzysztof Marlicz, Zbigniew Banaszkiewicz, Rafał Wiśniowski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A22

    This article is part of a Supplement: Volume 10 Supplement 3

  19. Authors: Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko-Grabarek, Oleg Ashuryk, Anna Jakubowska, Antoni Morawski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A21

    This article is part of a Supplement: Volume 10 Supplement 3

  20. Authors: Magdalena Muszyńska, Grzegorz Sukiennicki, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko-Grabarek, Oleg Ashuryk, Anna Jakubowska, Antoni Morawski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A17

    This article is part of a Supplement: Volume 10 Supplement 3

  21. Authors: Katarzyna Jaworska, Anna Jakubowska, Katarzyna Durda, Tomasz Huzarski, Pablo Serrano-Fernandez, Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Byrski, Jacek Gronwald, Satish Gupta, K Kaczmarek and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A8

    This article is part of a Supplement: Volume 10 Supplement 3

  22. Authors: Katrzyna Jaworska, Satish Gupta, Katarzyna Durda, Magdalena Muszynska, Grzegorz Sukiennicki, Elżbieta Jaworowska, Tomasz Grodzki, Mieczysław Sulikowski, Piotr Woloszczyk, Janusz Wójcik, Jakub Lubiński, Cezary Cybulski, Tadeusz Dębniak, Marcin Lener, Steven A Narod, Ping Sun…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A7

    This article is part of a Supplement: Volume 10 Supplement 3

  23. Authors: Katarzyna Durda, Anna Jakubowska, Krzysztof Kąklewski, Katarzyna Jaworska, Satish Gupta, Tomasz Byrski, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko, Oleg Ashuryk and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A6

    This article is part of a Supplement: Volume 10 Supplement 3

  24. We would like to present a patient with a classical phenotype of a rare disorder - Cowden syndrome, its diagnostics and management challenges. A breast surgeon has to be aware of this rare condition when treat...

    Authors: Inga Melbārde-Gorkuša, Arvīds Irmejs, Dace Bērziņa, Ilze Štrumfa, Arnis Āboliņš, Andris Gardovskis, Signe Subatniece, Genādijs Trofimovičs, Jānis Gardovskis and Edvīns Miklaševičs
    Citation: Hereditary Cancer in Clinical Practice 2012 10:5

Annual Journal Metrics

  • 2022 Citation Impact
    1.7 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.634 - SNIP (Source Normalized Impact per Paper)
    0.526 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    394,813 downloads
    196 Altmetric mentions